SEQVORA Labs illustration for this article.
Preclinical findings do not establish that self-administering BPC-157 is safe for humans.
Different levels of evidence
Several stages of testing separate a cell experiment from use in patients. As a reader, look at who or what was studied, how many participants were included, and whether the outcome was clinically meaningful.
Safety questions
The FDA notes limited safety data for BPC-157 and potential risks related to immune reactions and impurities. Availability in an online store does not resolve these concerns.
A separate consideration for athletes
Check anti-doping requirements against the current WADA Prohibited List. Discuss injury treatment with a sports physician; an online selection cannot account for your diagnosis or your sporting organisation's rules.
Sources
- FDA — Safety risks of substances used in compoundingSafety
- WADA — current Prohibited ListAnti-doping rules
A registry link lets you find studies; it does not confirm effectiveness. Learn more about our approach to sources.
